United StatesBreaking News

TransDigm Group (NYSE:TDG) agreed to acquire Prince & Izant for approximately $1.066 billion in cash, including certain tax benefits.

Honeywell Technologies (NASDAQ:HON) completed its all-cash WWS sale to American Industrial Partners, with financial terms undisclosed.

Costamare (NYSE:CMRE) reported second-quarter net income from continuing operations of $83.9 million and liquidity of $423 million.

Gossamer Bio (NASDAQ:GOSS) has announced a series of strategic and regulatory updates, highlighted by plans to submit a New Drug Application (NDA) for its lead candidate, seralutinib, in September 2026.

Alliance Resource Partners (NASDAQ:ARLP) reported second-quarter revenue of $551.6 million, up 0.7%, while net income increased 33.9% to $79.6 million.

Biohaven (NYSE:BHVN) and Yale University announced a favorable verdict from a federal jury in the U.S. District Court for the District of Delaware regarding their ongoing litigation against Avilar Therapeutics and RA Capital.

Bank of Hawai‘i (NYSE:BOH) reported second-quarter net income of $63.8 million, up 11.1% sequentially, with diluted EPS of $1.47.

Kura Oncology (NASDAQ:KURA) reported 33%–50% response rates for darlifarnib plus cabozantinib among 34 evaluable advanced kidney-cancer patients.

Perfect Corp. (NYSE:PERF) reported second-quarter net income of $1.3 million, up 518.4%, while revenue remained stable at $16.3 million.

Legend Biotech (NASDAQ:LEGN) announced a significant leadership transition, confirming that Ying Huang, Ph.D., has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors, effective July 24, 2026.

The Ensign Group (NASDAQ:ENSG) reported second-quarter revenue of $1.44 billion, up 17.3%, as occupancy and skilled-care revenue increased.

Rocket Lab (NASDAQ:RKLB) won a $266 million Space Force contract covering 12 suborbital vehicles and six optional launches.